🔎 Trials Near Me

Home › Bile Duct Cancer (Cholangiocarcinoma) › California

Bile Duct Cancer (Cholangiocarcinoma) clinical trials in California

20 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in California.

Cities in California

A Study of PHST001 in Advanced Solid Tumors

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Stanford University School of Medicine, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06840886

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

  • City of Hope (Site 107), Duarte
  • University of California at Irvine (Site 101), Orange
  • UCLA Medical Center (Site 117), Santa Monica
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07265674

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213791

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • START Los Angeles, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Stanford University, Palo Alto
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Recruiting
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05497531

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07619313

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

  • UCI Irvine Health, Orange
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07486713

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

  • City of Hope Medical Center, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05285358

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • LACN Aneheim Flagship Office, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05874414

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07337525

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

  • City of Hope Nat Medical Ctr, Duarte
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07224750

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

  • City of Hope Medical Center, Duarte
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT06342414

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  • USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07169734

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

  • University of California, Davis Comprehensive Cancer Center, Sacramento
Recruiting
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06101277

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Cedars-Sinai Medical Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07458347

A Study of MGC028 in Participants With Advanced Solid Tumors

  • UCSF - Helen Diller Family Cancer Center, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT06723236

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

  • Stanford University, Palo Alto
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT07223307

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • and 3 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.